ITRON, INC.

(a)No information was required to be disclosed in a report on Form 8-K during the third quarter of 2025 that was not reported.

(b)Not applicable.

(c)Insider Trading Arrangements

Our officers, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934 (the Exchange Act), and directors from time to time enter into contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) against liability for trading in securities on the basis of material nonpublic information. During the quarter ended September 30, 2025, the following Section 16 officers adopted, modified, or terminated trading arrangements (as defined in Item 408 of Regulation S-K of the Exchange Act):

•On September 9, 2025, Thomas L. Deitrich, President and Chief Executive Officer, adopted a written trading plan designed to be in effect until September 8, 2026 with respect to the exercise of up to 21,176 stock options of Itron, Inc. common stock, subject to certain conditions.

•On September 11, 2025, Donald L. Reeves, Senior Vice President, Outcomes, adopted a written trading plan designed to be in effect until September 2, 2026 with respect to the sale of up to 9,540 shares of Itron, Inc. common stock, subject to certain conditions.

•On September 16, 2025, Justin K. Patrick, Senior Vice President, Device Solutions, adopted a written trading plan designed to be in effect until September 2, 2026 with respect to the sale of up to 10,210 shares of Itron, Inc. common stock, subject to certain conditions.